Oculus Rift was the cornerstone of the future of VR
Michael Debets/Pacific Press/LightRocket via Getty Images The system that helped grow VR's popularity was the Oculus Rift. Meta's VR division discontinued the Rift in 2020 to focus on the Oculus Quest system. On paper, the Quest is superior to the Rift, but which device suits you is personal. In…#vr #oculusrift #meta #quest #lawnmowerman #oculusrifts #oculusinsight #rifts #realitylabs #oculusquestvr
Source: Reuters: Health - September 16, 2023 Category: Consumer Health News Source Type: news

Scientists create cancer-killing treatment they hope will annihilate most aggressive tumours
Scientists in Nottingham have discovered a new way to use nanoparticles to induce cell death, known scientifically as apoptosis, in glioblastoma cells - one of the most aggressive forms of brain cancer.
Source: the Mail online | Health - September 15, 2023 Category: Consumer Health News Source Type: news

FDA Approves Ojjaara (momelotinib) for Myelofibrosis Patients with Anemia
Approval is for use in myelofibrosis patients with anemia regardless of prior myelofibrosis therapy Nearly all myelofibrosis patients are estimated to develop anemia over the course of the disease, and over 30% will discontinue treatment due to...
Source: Drugs.com - New Drug Approvals - September 15, 2023 Category: Drugs & Pharmacology Source Type: news

Humacyte enters critical phase for its bioengineered tissue
A Durham company is preparing to seek federal approval for its trauma treatment in order to advance to commercialization following positive trial data.
Source: bizjournals.com Health Care:Biotechnology headlines - September 15, 2023 Category: Biotechnology Authors: Zac Ezzone Source Type: news

Former J & J CEO Alex Gorsky named lead director at RI-based Neurotech Pharmaceuticals
Neurotech is developing novel technologies for the treatment of chronic eye diseases.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 15, 2023 Category: Pharmaceuticals Authors: Mary Serreze Source Type: news

Reassuring Real-World Data on Redo TAVR Reassuring Real-World Data on Redo TAVR
Registry data suggest repeated transcatheter aortic valve replacement with a balloon-expandable valve is a reasonable treatment for failed TAVR.Medscape Medical News
Source: Medscape Medical News Headlines - September 15, 2023 Category: Consumer Health News Tags: Cardiology News Source Type: news

Scientists already knew that magic mushrooms were good for mental health, but they just discovered the rave drug MDMA can help people struggling with PTSD
The psychedelic drug MDMA can reduce symptoms of post-traumatic stress disorder, researchers reported in a new study published Thursday. The company sponsoring the research said it plans later this year to seek U.S. approval to market the drug, also known as ecstasy, as a PTSD treatment when…#mdma #itsfirst #amyemerson #barbararothbaum #atlanta #naturemedicine #schedule1
Source: Reuters: Health - September 15, 2023 Category: Consumer Health News Source Type: news

FC Barcelona Coach Xavi Snaps At Media On Lamine Yamal Treatment Ahead Of Real Betis Match
FC Barcelona head coach Xavi Hernandez took a dig at the media during his pre-match press conference ahead of Saturday's La Liga clash with Real Betis. The manager was probed on how to handle teenage phenomenon Lamine Yamal, who debuted against this weekend's opposition as a 15-year-old last…#fc #barcelona #xavihernandez #laliga #realbetis #lamineyamal #barca #spain #laroja #pedri
Source: Reuters: Health - September 15, 2023 Category: Consumer Health News Source Type: news

The Great Exodus: Why Are Japanese Investors Choosing XRP Over Bitcoin?
A recent study has revealed that Japanese investors are choosing to invest in Ripple’s XRP over the world’s flagship cryptocurrency, Bitcoin. XRP Over Bitcoin And Ethereum In contrast to the treatment Ripple and the XRP token are receiving in the US, Japan seems more welcoming to the crypto asset,…#ripplesxrp #xrp #bitcoinandethereum #ripple #cityuniversity #hongkong #sbiholdings #sbirippleasia #dlt #southeastasian
Source: Reuters: Health - September 15, 2023 Category: Consumer Health News Source Type: news

Treatment of Lower Urinary Tract Symptoms Tied to Reduced Risk for Death in Men
FRIDAY, Sept. 15, 2023 -- For men with lower urinary tract symptoms, treatment is associated with a reduced risk for death, according to a study published in the Oct. 1 issue of The Journal of Urology. Blayne Welk, M.D., and J. Andrew McClure, from...
Source: Drugs.com - Pharma News - September 15, 2023 Category: Pharmaceuticals Source Type: news

Ecstasy from your doctor in six months? Makers of MDMA drug for trauma patients to ask FDA to approve psychedelic treatment
MDMA is on the verge of being approved in the US after showing promise as a powerful treatment for post-traumatic stress disorder (PTSD) in its final trial results.
Source: the Mail online | Health - September 15, 2023 Category: Consumer Health News Source Type: news

Success of MDMA in PTSD Study Could Pave the Way for U.S. Approval of the Psychedelic
The psychedelic drug MDMA can reduce symptoms of post-traumatic stress disorder, researchers reported in a new study published Thursday. The company sponsoring the research said it plans later this year to seek U.S. approval to market the drug, also known as ecstasy, as a PTSD treatment when combined with talk therapy. “It’s the first innovation in PTSD treatment in more than two decades. And it’s significant because I think it will also open up other innovation,” said Amy Emerson, CEO of MAPS Public Benefit Corporation, the research sponsor. [time-brightcove not-tgx=”true”] ...
Source: TIME: Health - September 15, 2023 Category: Consumer Health News Authors: CARLA K. JOHNSON / AP Tags: Uncategorized wire Source Type: news

NEDHSA announces Inaugural Recovery Celebration with September 15 event at Forsythe Park
Northeast Delta Human Services Authority (NEDHSA) announces its inaugural Recovery Day Celebration, an event created to raise awareness of mental health and substance use disorders, celebrate individuals in recovery, and acknowledge the work of prevention, treatment, and recovery support...
Source: PRWeb: Medical Pharmaceuticals - September 15, 2023 Category: Pharmaceuticals Source Type: news

Cingulate raises $4M from public offering of almost 7M shares
KCK-based Cingulate completed a 6.9 million-share offering for almost 58 cents a share. The company is pushing its first time-release ADHD drug through clinical trials.
Source: bizjournals.com Health Care:Biotechnology headlines - September 15, 2023 Category: Biotechnology Authors: Russell Gray Source Type: news

Shortage of scabies treatment ‘likely to become a major public health issue’, expert warns
The shortage of treatment for scabies "is likely to become a major public health issue", a health official has warned.
Source: Daily Express - Health - September 15, 2023 Category: Consumer Health News Source Type: news

Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20